Skip to content
healthcare.dev

Xylocaine MPF

NDC 65219-812, LIDOCAINE HYDROCHLORIDE, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-812
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA006488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE ANHYDROUS20 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
65219-812-026521908120225 VIAL, SINGLE-DOSE in 1 TRAY (65219-812-02) / 2 mL in 1 VIAL, SINGLE-DOSE (65219-812-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fe265eb5-eaeb-4f47-82dd-238c1d53fec4

Use it

Look up 65219-812 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.